ozempic semaglutide weight loss off-label Prescription of diabetes drug for 'contributing to UK shortage' | Diabetes Wegovy® Lawsuit | July 2026

In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time

Most patients see their healthcare provider every 4-6 weeks during the initial dosing phase

Switching plan: what timing is safest if changing therapies

Wegovy and Zepbound are now fully FDA approved for chronic weight management, regardless of diabetes status, as long as you meet the BMI or health condition criteria

Table of Contents What Are GLP-1 Medications and How Do They Work